Hims & Hers' $49 weight-loss pill jolts everyone, except its stock

NEW YORK, Feb 6 (Reuters) - Hims & Hers sent a shockwave through the pharmaceutical industry on Thursday with its ...

A Cheaper Wegovy Pill Alternative Is Hitting the Market. Here’s What You Need to Know

By comparison, Novo Nordisk’s Wegovy pill—launched earlier this year and already used by more than 170,000 people, CEO Mike ...

Hims & Hers launches compounded semaglutide pill as lower-cost weight loss option

Hims & Hers (NYSE:HIMS) has announced the launch of a compounded semaglutide pill designed for weight loss, providing an ...
Fierce Healthcare

Him & Hers plans to offer cheaper version of Wegovy pill, prompting Novo Nordisk to threaten legal action

A month after drugmaker Novo Nordisk launched its Wegovy pill, online health and wellness company Hims & Hers plans to ...
Devdiscourse

Hims & Hers' Disruptive Move with Compounded Weight-Loss Pills

Hims & Hers plans to launch a compounded version of Novo Nordisk's Wegovy pill at $49 a month. This move, echoing its ...

Hims GLP-1 Weight Loss: What Consumers Should Know About the Reported $49 Compounded Semaglutide Pill, Novo Nordisk Response, and Telehealth Prescriptio…

An informational overview of reported February 2026 developments, FDA-approved vs. compounded medication distinctions, Wegovy ...